| Bitter melon (Momordica charantia): a review of efficacy and safety E Basch, S Gabardi, C Ulbricht American Journal of Health-System Pharmacy 60 (4), 356-359, 2003 | 688 | 2003 |
| Pharmacoepidemiology of anemia in kidney transplant recipients WC Winkelmayer, R Kewalramani, M Rutstein, S Gabardi, T Vonvisger, ... Journal of the American Society of Nephrology 15 (5), 1347-1352, 2004 | 182 | 2004 |
| Drug dosing in chronic kidney disease S Gabardi, S Abramson Medical Clinics 89 (3), 649-687, 2005 | 142 | 2005 |
| Everolimus: a proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiology S Gabardi, SA Baroletti Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 30 (10 …, 2010 | 129 | 2010 |
| Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation S Gabardi, SS Waikar, S Martin, K Roberts, J Chen, L Borgi, H Sheashaa, ... Clinical Journal of the American Society of Nephrology 5 (7), 1298-1304, 2010 | 129 | 2010 |
| Antibody‐mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options M Kim, ST Martin, KR Townsend, S Gabardi Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (7 …, 2014 | 128 | 2014 |
| CMV and BKPyV infections in renal transplant recipients receiving an mTOR inhibitor–based regimen versus a CNI-based regimen: a systematic review and meta-analysis of … SG Mallat, BY Tanios, HS Itani, T Lotfi, C McMullan, S Gabardi, EA Akl, ... Clinical Journal of the American Society of Nephrology 12 (8), 1321-1336, 2017 | 125 | 2017 |
| A review of dietary supplement–induced renal dysfunction S Gabardi, K Munz, C Ulbricht Clinical Journal of the American Society of Nephrology 2 (4), 757-765, 2007 | 115 | 2007 |
| Dyslipidemia and its therapeutic challenges in renal transplantation LV Riella, S Gabardi, A Chandraker American Journal of Transplantation 12 (8), 1975-1982, 2012 | 113 | 2012 |
| Efficacy and safety of direct acting antivirals in kidney transplant recipients with chronic hepatitis C virus infection MV Lin, ME Sise, M Pavlakis, BM Amundsen, D Chute, AE Rutherford, ... PLoS One 11 (7), e0158431, 2016 | 112 | 2016 |
| A rationale for age-adapted immunosuppression in organ transplantation F Krenzien, A ElKhal, M Quante, HRC Biefer, U Hirofumi, S Gabardi, ... Transplantation 99 (11), 2258-2268, 2015 | 106 | 2015 |
| Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial BT Lee, S Gabardi, M Grafals, RM Hofmann, E Akalin, A Aljanabi, ... Clinical Journal of the American Society of Nephrology 9 (3), 583-589, 2014 | 104 | 2014 |
| Evolution of the role of the transplant pharmacist on the multidisciplinary transplant team RR Alloway, R Dupuis, S Gabardi, TE Kaiser, DJ Taber, EM Tichy, ... American Journal of Transplantation 11 (8), 1576-1583, 2011 | 98 | 2011 |
| Induction immunosuppressive therapies in renal transplantation S Gabardi, ST Martin, KL Roberts, M Grafals American Journal of Health-System Pharmacy 68 (3), 211-218, 2011 | 97 | 2011 |
| Invasive fungal infections and antifungal therapies in solid organ transplant recipients S Gabardi, DW Kubiak, AK Chandraker, SG Tullius Transplant International 20 (12), 993-1015, 2007 | 91 | 2007 |
| Mycophenolate fetal toxicity and risk evaluation and mitigation strategies M Kim, S Rostas, S Gabardi American Journal of Transplantation 13 (6), 1383-1389, 2013 | 88 | 2013 |
| Current trends in immunosuppressive therapies for renal transplant recipients RA Lee, S Gabardi American Journal of Health-System Pharmacy 69 (22), 1961-1975, 2012 | 86 | 2012 |
| A multicenter experience with generic tacrolimus conversion LM McDevitt-Potter, B Sadaka, EM Tichy, CC Rogers, S Gabardi Transplantation 92 (6), 653-657, 2011 | 82 | 2011 |
| Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates M Kim, KR Townsend, IG Wood, S Boukedes, I Guleria, S Gabardi, ... American journal of respiratory and critical care medicine 189 (10), 1234-1239, 2014 | 78 | 2014 |
| Efficacy and safety of low‐dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: a single‐center, retrospective analysis S Gabardi, CC Magee, SA Baroletti, JA Powelson, JL Cina, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 24 (10 …, 2004 | 76 | 2004 |
